Analysis of the correlation between levels of cytokines and the clinical active severity in patients with Graves ophthalmopathy
Xie Rongrong, Shi Tingting, Xin Zhong, Cao Xi, Yang Jinkui
2023, 44(3):
407-412.
doi:10.3969/j.issn.1006-7795.2023.03.008
Asbtract
(
117 )
PDF (1649KB)
(
47
)
References |
Related Articles |
Metrics
Objective To explore the correlation between plasma levels of 12 cytokines and the clinical activity of the disease in patients with Graves' ophthalmopathy (GO) in active and inactive phases. Methods A total of 27 patients with GO were enrolled, who were diagnosed in the Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University from January 2021 to January 2023. According to their Clinical Activity Score (CAS), the patients were divided into active phase group (14 cases, CAS ≥ 3) and inactive phase group (13 cases, CAS<3) The levels of 12 cytokines in plasma were measured by multiple microsphere flow immunofluorescence luminescence method, including interleukin (IL)-1β IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-17, IL-12P70, interferon (IFN)-α, IFN-γ, and tumor necrosis factor (TNF)-α. The clinical characteristics such as gender, age, liver and kidney function, thyroid function, and antibody of all the subjects were collected. Results The levels of IL-1, IL-4, IL-5, IL-8, IL-10, IL-17, IFN-γ and TNF-α in active GO patients were significantly higher than those in inactive GO patients. Levels of TNF-α and IFN-γ were significantly increased in active GO patients, with statistically significant difference (P<0.05). Spearman correlation analysis showed that IL-1, IL-4, IL-5, IL-8, IL-10, IL-17, TNF-α and IFN-γ were significantly positively correlated with CAS score (P< 0.05). The univariate logistic regression showed that the elevated levels of IL-1, IL-4, IL-5 and IL-17 increase the risk of active phase. Conclusion The levels of IL-1, IL-4, IL-5, IL-8, IL-10 and IL-17 in active GO patients are significantly higher than those in inactive patients, suggesting that these cytokines may participate in the immune response of the disease. Elevated levels of IL-1, IL-4, IL-5 and IL-17 increase the risk of active phase, indicating a potential of these four cytokines as indicators for judging the activity of GO disease.